These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21424594)

  • 21. Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.
    Blin N; Camoin L; Maigret B; Strosberg AD
    Mol Pharmacol; 1993 Dec; 44(6):1094-104. PubMed ID: 7903415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2D-QSAR and 3D-QSAR/CoMSIA Studies on a Series of (R)-2-((2-(1H-Indol-2-yl)ethyl)amino)-1-Phenylethan-1-ol with Human β₃-Adrenergic Activity.
    Apablaza G; Montoya L; Morales-Verdejo C; Mellado M; Cuellar M; Lagos CF; Soto-Delgado J; Chung H; Pessoa-Mahana CD; Mella J
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28273884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Site-directed mutagenesis of the human beta3-adrenoceptor--transmembrane residues involved in ligand binding and signal transduction.
    Gros J; Manning BS; Pietri-Rouxel F; Guillaume JL; Drumare MF; Strosberg AD
    Eur J Biochem; 1998 Feb; 251(3):590-6. PubMed ID: 9490030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An insilico approach to high altitude pulmonary edema - Molecular modeling of human beta2 adrenergic receptor and its interaction with Salmeterol & Nifedipine.
    Chandramoorthi GD; Piramanayagam S; Marimuthu P
    J Mol Model; 2008 Sep; 14(9):849-56. PubMed ID: 18512086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an update.
    Weyer C; Gautier JF; Danforth E
    Diabetes Metab; 1999 Mar; 25(1):11-21. PubMed ID: 10335419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography.
    Wacker D; Fenalti G; Brown MA; Katritch V; Abagyan R; Cherezov V; Stevens RC
    J Am Chem Soc; 2010 Aug; 132(33):11443-5. PubMed ID: 20669948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationship studies of phenoxypropanolamine derivatives for beta 3-adrenergic activity.
    Ahmed M; Hanaoka Y; Nagatomo T
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):112P-113P. PubMed ID: 12491799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of Novel Indazole Derivatives as Highly Potent and Selective Human β3-Adrenergic Receptor Agonists with the Possibility of Having No Cardiovascular Side Effects.
    Wada Y; Shirahashi H; Iwanami T; Ogawa M; Nakano S; Morimoto A; Kasahara K; Tanaka E; Takada Y; Ohashi S; Mori M; Shuto S
    J Med Chem; 2015 Aug; 58(15):6048-57. PubMed ID: 26125514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the beta2-adrenergic receptor: part 6.
    Hattori K; Orita M; Toda S; Imanishi M; Itou S; Nakajima Y; Tanabe D; Washizuka K; Araki T; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4679-83. PubMed ID: 19608416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists.
    Isogaya M; Sugimoto Y; Tanimura R; Tanaka R; Kikkawa H; Nagao T; Kurose H
    Mol Pharmacol; 1999 Nov; 56(5):875-85. PubMed ID: 10531390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human beta3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moieties.
    Brockunier LL; Candelore MR; Cascieri MA; Liu Y; Tota L; Wyvratt MJ; Fisher MH; Weber AE; Parmee ER
    Bioorg Med Chem Lett; 2001 Feb; 11(3):379-82. PubMed ID: 11212115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.
    Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R
    J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators.
    Reynolds KA; Katritch V; Abagyan R
    J Comput Aided Mol Des; 2009 May; 23(5):273-88. PubMed ID: 19148767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The unique nature of the serine interactions for alpha 1-adrenergic receptor agonist binding and activation.
    Hwa J; Perez DM
    J Biol Chem; 1996 Mar; 271(11):6322-7. PubMed ID: 8626427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of β3-adrenergic receptors contributes to atrial structural remodeling in rapid pacing induced atrial fibrillation canines.
    Sheng L; Shen Q; Huang K; Liu G; Zhao J; Xu W; Liu Y; Li W; Li Y
    Cell Physiol Biochem; 2012; 30(2):372-81. PubMed ID: 22739404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular modeling of SWR-0342SA, a beta3-selective agonist, with beta1- and beta3-adrenoceptor.
    Ahmed M; Ishiguro M; Nagatomo T
    Life Sci; 2006 Mar; 78(17):2019-23. PubMed ID: 16310810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors.
    Emtage AL; Mistry SN; Fischer PM; Kellam B; Laughton CA
    J Biomol Struct Dyn; 2017 Sep; 35(12):2604-2619. PubMed ID: 27532213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human beta3 adrenergic receptor agonists.
    Parmee ER; Brockunier LL; He J; Singh SB; Candelore MR; Cascieri MA; Deng L; Liu Y; Tota L; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2283-6. PubMed ID: 11055339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists.
    Kim SK; Gao ZG; Van Rompaey P; Gross AS; Chen A; Van Calenbergh S; Jacobson KA
    J Med Chem; 2003 Nov; 46(23):4847-59. PubMed ID: 14584936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of beta3-adrenergic receptor activation on rat urinary bladder hyperactivity induced by ovariectomy.
    Kullmann FA; Limberg BJ; Artim DE; Shah M; Downs TR; Contract D; Wos J; Rosenbaum JS; de Groat WC
    J Pharmacol Exp Ther; 2009 Sep; 330(3):704-17. PubMed ID: 19515967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.